|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.02.26 - 07:06
|
Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 million (GlobeNewswire EN)
|
|
|
Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 millionRotterdam, the Netherlands, 25th February 2026Vopak intends to commence a multi-year share buyback program of up to EUR 500 million, expected to be executed by year-end of 2030 in multiple tranches. This share buyback program is part of the shareholder distributions program of around EUR 1.7 billion through year-end 2030. In addition to the multi-year share buyback program, Vopak has enhanced the progressive dividend policy, through which the company intends to increase its dividend per share by 5% or more annually. For further details please refer to the FY 2025 press release published on 25 February 2026.The first tranche of the multi-year share buyback program, of up to EUR 100 million, will commence on 26 February 2026 and end no later than 26 February 2027, barring unforeseen circumstances. Vopak will cancel the repurchased shares subject to the relevant board and shareh...
|
|
|
25.02.26 - 07:03
|
TextMagic AS 2025 12 months consolidated unaudited interim report (GlobeNewswire EN)
|
|
|
The year 2025 in the TextMagic Group was characterised by several strategic decisions aimed at improving performance and operational efficiency in future periods. During the year, structural changes were implemented, including the sale of one business line and the initiation of the liquidation of a subsidiary, as well as the optimisation of development activities and the cost base....
|
|
|
|
|
|
|
25.02.26 - 07:03
|
Vow ASA: Record Q4 revenues and strategy revision concluded (GlobeNewswire EN)
|
|
|
Oslo, 25 February 2026 – In the fourth quarter, Vow ASA (“Vow” or the “Group”) delivered all time high revenues and improved operational performance. Following the strategy revision, which was concluded in the period, the Group aims to reinforce its position in the Maritime Solutions and Aftersales segments, while a more selective approach will be adopted in the Industrial Solutions Segment....
|
|
|
|
|
|
|
|
|
|
|
25.02.26 - 05:15
|
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire EN)
|
|
|
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the pricing of an underwritten public offering of 7,175,000 shares of its common stock at a public offering price of $16.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 2,200,000 shares of common stock at a public offering price of $15.9999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. The gross proceeds to Bicara from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Bicara, are expected to be approximately $150 million, excluding any exercise of the underwriters' option to purchase additional shares and excluding the exercise of any pre-...
|
|
|
|
|
|